Mergers & Acquisitions: Page 3

Danaher to acquire Abcam for $5.7B

By LabPulse.com staff writers

Science and medical technology firm Danaher announced Monday that it has entered into an agreement to acquire Abcam, a Cambridge, U.K.-based supplier of antibodies, reagents, biomarkers, and assays.

August 29, 2023

Agilent closes $550M liquid biopsy unit after failing to find path to profits

By Nick Paul Taylor

When Agilent bought Resolution, it identified the company’s presence in fast-growing NGS technologies for precision oncology as a way to expand its addressable market; rather than realizing that opportunity, Agilent has ended up cutting its losses.

August 18, 2023

New Day Diagnostics inks $12M deal to buy Epigenomics’ cancer technology

By Nick Paul Taylor

Epigenomics has agreed to sell “substantially all” of its assets to New Day Diagnostics, a developer of tests for the early detection and monitoring of disease that merged with EDP Biotech earlier this month.

July 31, 2023

Vector Laboratories buys Quanta Bio for polyethylene glycol technology

By Nick Paul Taylor

Single molecular weight, discrete-length PEG chains such as Quanta’s dPEG products can simplify peptide analysis compared to other products that contain a range of PEG chain lengths and molecular weights.

July 24, 2023

Applied DNA buys Spindle Biotech to improve mRNA production offering

By Nick Paul Taylor

New York-based Applied DNA will integrate its LinearDNA platform and Spindle’s RNAP to make LineaIVT, a platform that it claims will address challenges facing manufacturers of mRNA vaccines and therapies.

July 20, 2023

Novacyt to purchase Yourgene for $21.2M

By LabPulse.com staff writers

In a statement, the Camberley, U.K.-based Novacyt said that the acquisition of Yourgene will diversify and expand its testing offerings and geographic footprint, a strategy in part prompted by falling demand for Novacyt’s COVID-19 testing services.

July 11, 2023

FTC mulls changes to company merger rules

By LabPulse.com staff writers

The proposed rule change would amend the Hart-Scott-Rodino (HSR) form and instructions, the first time in 45 years that the agencies will perform a top-to-bottom review of the form.

June 29, 2023

Intus Bio buys Pattern Genomics to enhance microbiome analysis capabilities

By Nick Paul Taylor

Intus Bio sees the integration enhancing the platform with machine-learning tools for biomarker discovery and patient stratification, supporting the firm’s work in turning microbiome technologies into practical medical and pharmaceutical applications.

June 29, 2023

Genomics AI firm Genomenon acquires Boston Genetics

By LabPulse.com staff writers

An expanded genomic interpretation team enabled by the acquisition supports its offerings for clinical diagnostic and pharmaceutical drug development programs, Genomenon said.

June 27, 2023

Bio-Techne to acquire Swiss spatial biology firm Lunaphore

By LabPulse.com staff writers

Bio-Techne said that it expects to close the deal by the end of September, in the first quarter of its fiscal 2024.

June 22, 2023

Quest Diagnostics completes acquisition of Haystack Oncology, adds MRD liquid biopsy to Dx portfolio

By LabPulse.com staff writers

Quest expects next year to use the MRD technology in blood-based clinical lab testing services for solid tumor cancers.

June 21, 2023

Mars Petcare completes acquisition of Heska

By LabPulse.com staff writers

Heska is now part of Mars Petcare’s Science & Diagnostics division, enabling Mars to accelerate research and development and expand access to diagnostics and technology to more veterinary professionals and pets, Mars said.

June 13, 2023

Previous Page

Page 3 of 11

Next Page